These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30635136)
1. Phenotypic features of 1q41q42 microdeletion including WDR26 and FBXO28 are clinically recognizable: The first case from Japan. Yanagishita T; Yamamoto-Shimojima K; Nakano S; Sasaki T; Shigematsu H; Imai K; Yamamoto T Brain Dev; 2019 May; 41(5):452-455. PubMed ID: 30635136 [TBL] [Abstract][Full Text] [Related]
2. Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures. Au PY; Argiropoulos B; Parboosingh JS; Micheil Innes A Am J Med Genet A; 2014 Feb; 164A(2):441-8. PubMed ID: 24357076 [TBL] [Abstract][Full Text] [Related]
3. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype. Balak C; Belnap N; Ramsey K; Joss S; Devriendt K; Naymik M; Jepsen W; Siniard AL; Szelinger S; Parker ME; Richholt R; Izatt T; LaFleur M; Terraf P; Llaci L; De Both M; Piras IS; Rangasamy S; Schrauwen I; Craig DW; Huentelman M; Narayanan V Am J Med Genet A; 2018 Jul; 176(7):1549-1558. PubMed ID: 30160831 [TBL] [Abstract][Full Text] [Related]
4. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome. Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845 [TBL] [Abstract][Full Text] [Related]
5. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features. Skraban CM; Wells CF; Markose P; Cho MT; Nesbitt AI; Au PYB; Begtrup A; Bernat JA; Bird LM; Cao K; de Brouwer APM; Denenberg EH; Douglas G; Gibson KM; Grand K; Goldenberg A; Innes AM; Juusola J; Kempers M; Kinning E; Markie DM; Owens MM; Payne K; Person R; Pfundt R; Stocco A; Turner CLS; Verbeek NE; Walsh LE; Warner TC; Wheeler PG; Wieczorek D; Wilkens AB; Zonneveld-Huijssoon E; ; Kleefstra T; Robertson SP; Santani A; van Gassen KLI; Deardorff MA Am J Hum Genet; 2017 Jul; 101(1):139-148. PubMed ID: 28686853 [TBL] [Abstract][Full Text] [Related]
6. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Shaffer LG; Theisen A; Bejjani BA; Ballif BC; Aylsworth AS; Lim C; McDonald M; Ellison JW; Kostiner D; Saitta S; Shaikh T Genet Med; 2007 Sep; 9(9):607-16. PubMed ID: 17873649 [TBL] [Abstract][Full Text] [Related]
7. FBXO28 is a critical gene of the 1q41q42 microdeletion syndrome. Cassina M; Rigon C; Casarin A; Vicenzi V; Salviati L; Clementi M Am J Med Genet A; 2015 Jun; 167(6):1418-20. PubMed ID: 25900767 [No Abstract] [Full Text] [Related]
10. Molecular cytogenetic characterization of a de novo chromosome 1q41-q42.11 microdeletion of paternal origin in a 15-year-old boy with mental retardation, developmental delay, autism and congenital heart defects. Chen CP; Chern SR; Wu PS; Chen SW; Wu FT; Wang W Taiwan J Obstet Gynecol; 2021 Mar; 60(2):341-344. PubMed ID: 33678339 [TBL] [Abstract][Full Text] [Related]
11. Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25. Burkardt DD; Rosenfeld JA; Helgeson ML; Angle B; Banks V; Smith WE; Gripp KW; Moline J; Moran RT; Niyazov DM; Stevens CA; Zackai E; Lebel RR; Ashley DG; Kramer N; Lachman RS; Graham JM Am J Med Genet A; 2011 Jun; 155A(6):1336-51. PubMed ID: 21548129 [TBL] [Abstract][Full Text] [Related]
12. Interstitial deletion 1q42 in a patient with agenesis of corpus callosum: Phenotype-genotype comparison to the 1q41q42 microdeletion suggests a contiguous 1q4 syndrome. Filges I; Röthlisberger B; Boesch N; Weber P; Wenzel F; Huber AR; Heinimann K; Miny P Am J Med Genet A; 2010 Apr; 152A(4):987-93. PubMed ID: 20358614 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular characterization of an emerging chromosome 22q13.31 microdeletion syndrome. Palumbo P; Accadia M; Leone MP; Palladino T; Stallone R; Carella M; Palumbo O Am J Med Genet A; 2018 Feb; 176(2):391-398. PubMed ID: 29193617 [TBL] [Abstract][Full Text] [Related]
14. 19q13.32 microdeletion syndrome: three new cases. Castillo A; Kramer N; Schwartz CE; Miles JH; DuPont BR; Rosenfeld JA; Graham JM Eur J Med Genet; 2014; 57(11-12):654-8. PubMed ID: 25230004 [TBL] [Abstract][Full Text] [Related]
16. Clinical characterization of DISP1 haploinsufficiency: A case report. Jun KR; Hur YJ; Lee JN; Kim HR; Shin JH; Oh SH; Lee JY; Seo EJ Eur J Med Genet; 2013 Jun; 56(6):309-13. PubMed ID: 23542665 [TBL] [Abstract][Full Text] [Related]
17. The crucial role of FBXO28 in the pathogenesis of the 1q41q42 microdeletion syndrome. Papetti L; Schettini L; Garone G; Gennaro E; Malacarne M; Properzi E; Spalice A Am J Med Genet A; 2016 Nov; 170(11):3041-3042. PubMed ID: 27184008 [No Abstract] [Full Text] [Related]
18. ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome. Zak J; Vives V; Szumska D; Vernet A; Schneider JE; Miller P; Slee EA; Joss S; Lacassie Y; Chen E; Escobar LF; Tucker M; Aylsworth AS; Dubbs HA; Collins AT; Andrieux J; Dieux-Coeslier A; Haberlandt E; Kotzot D; Scott DA; Parker MJ; Zakaria Z; Choy YS; Wieczorek D; Innes AM; Jun KR; Zinner S; Prin F; Lygate CA; Pretorius P; Rosenfeld JA; Mohun TJ; Lu X Cell Death Differ; 2016 Dec; 23(12):1973-1984. PubMed ID: 27447114 [TBL] [Abstract][Full Text] [Related]
19. Compound heterozygous microdeletion of chromosome 15q13.3 region in a child with hypotonia, impaired vision, and global developmental delay. Prasun P; Hankerd M; Kristofice M; Scussel L; Sivaswamy L; Ebrahim S Am J Med Genet A; 2014 Jul; 164A(7):1815-20. PubMed ID: 24700535 [TBL] [Abstract][Full Text] [Related]
20. A de novo 10p11.23-p12.1 deletion recapitulates the phenotype observed in WAC mutations and strengthens the role of WAC in intellectual disability and behavior disorders. Abdelhedi F; El Khattabi L; Essid N; Viot G; Letessier D; Lebbar A; Dupont JM Am J Med Genet A; 2016 Jul; 170(7):1912-7. PubMed ID: 27119754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]